INNATE PHARMA: ifrs:CashFlowsFromUsedInInvestingActivities
| Value | {"amount": 20631000.0} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | INNATE PHARMA |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/f20162a3-4808-4605-9bbd-b4de84433a91
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:9695002Y8420ZB8HJE29:2023-12-31Retrieved: 2026-08-24T00:10:15.202100+02:00
Raw response sha256:
8cc6e40d8d62bf3f280603498c300fb9…Cite as: FACTANKER, https://factanker.com/fact/f20162a3-4808-4605-9bbd-b4de84433a91
History
- supersedes {"amount": 20630000.0} (evidence esef:9695002Y8420ZB8HJE29:2024-12-31)